Publications by authors named "Yalcin Serap"

Claim this Profile
,
, , and Studies of Umbelliferone and Irinotecan on MDA-MB-231 Breast Cancer Cell Line and Larvae.
Erkut Tamturk, Serap Yalcın, Fahriye Ercan, Aydın Suzu Tuncbilek

Anticancer Agents Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative activity and interaction with proteins of N-cyclohexylacrylamide.
Nevin Çankaya, Serap Yalçin

Saudi J Biol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data.
Fatma Kubra Ata, Serap Yalcin

Anticancer Agents Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
detection of inhibitor potential of compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses.
Serap Yalçın, Seda Yalçınkaya, Fahriye Ercan

J Mol Struct· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
Maryam Parsian, Pelin Mutlu, Serap Yalcin, Ufuk Gunduz

Anticancer Agents Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Potential Drug Candidate Molecules of the for COVID-19 Treatment.
Serap Yalçın, Seda Yalçınkaya, Fahriye Ercan

Curr Pharmacol Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approach.
Melih Sentürk, Fahriye Ercan, Serap Yalcin

Cancer Chemother Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.
Serap Yalcin

Pharm Dev Technol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutation in colorectal carcinomas with signet ring cell component.
Serap Yalcin, Onder Onguru

Cancer Biol Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Maryam Parsian, Pelin Mutlu, Serap Yalcin, Aysen Tezcaner, Ufuk Gunduz

Int J Pharm· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle-based drug delivery in cancer: the role of cell membrane structures.
Serap Yalçın, Özlem Özlüer, Ufuk Gündüz

Ther Deliv· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
Maryam Parsian, Gozde Unsoy, Pelin Mutlu, Serap Yalcin, Aysen Tezcaner

Eur J Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines.
Onder Onguru, Serap Yalcin, Cinthia Rosemblit, Paul J Zhang, Selim Kilic

Biomed Pharmacother· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Serap Yalçın, Pelin Mutlu, Türker Çetin, Meral Sarper, Gökhan Özgür

Turk J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.
Pelin Mutlu, Murad Mutlu, Serap Yalçın, Atılay Yaylacı, Gözde Ünsoy

Eur Arch Otorhinolaryngol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Serap Yalcin, Gozde Unsoy, Pelin Mutlu, Rouhollah Khodadust, Ufuk Gunduz

Am J Ther· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
Pelin Mutlu, Murad Mutlu, Serap Yalcin, Gozde Unsoy, Atilay Yaylaci

J BUON· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of -174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients.
Pelin Mutlu, Serap Yalcin, Pinar Elci, Murat Yildirim, A Turker Cetin

J BUON· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
Gozde Unsoy, Rouhollah Khodadust, Serap Yalcin, Pelin Mutlu, Ufuk Gunduz

Eur J Pharm Sci· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
Ahu Izgi, Armagan Gunal, Serap Yalcin, Ufuk Gunduz

Biomed Pharmacother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines.
Serap Yalçin, Mert Erkan, Gözde Ünsoy, Maryam Parsian, Jörg Kleeff

Biomed Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Ufuk Gunduz, Tugba Keskin, Gulistan Tansık, Pelin Mutlu, Serap Yalcin

Biomed Pharmacother· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.
Gozde Unsoy, Serap Yalcin, Rouhollah Khodadust, Pelin Mutlu, Onder Onguru

Biomed Pharmacother· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles.
Khodadust Rouhollah, Mutlu Pelin, Yalcin Serap, Unsoy Gozde, Gunduz Ufuk

J Pharm Sci· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship of the BRAF(V600E) mutation and the established prognostic factors in papillary thyroid carcinomas.
Bülent Kurt, Serap Yalçın, Engin Alagöz, Yıldırım Karslıoğlu, Nuri Yigit

Endocr Pathol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis